Durham, NC, United States of America

Antonio Landavazo

This inventor holds 1 USPTO granted patent. Top assignee: Glaxo Wellcome Inc.. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Antonio Landavazo. Retrieved from https://idiyas.com/inventor/antonio-landavazo-9ix3lp6e

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Antonio Landavazo: Innovator in Neuropeptide Research

Introduction

Antonio Landavazo is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of neuropeptide research, particularly through his innovative work on neuropeptide Y antagonists. His dedication to advancing scientific knowledge is reflected in his patent portfolio.

Latest Patents

Antonio holds a patent for neuropeptide Y antagonists, showcasing his expertise in this specialized area of research. This patent represents a crucial step in understanding the role of neuropeptides in various biological processes.

Career Highlights

Antonio is currently employed at Glaxo Wellcome Inc., where he continues to push the boundaries of pharmaceutical research. His work at this prominent company allows him to collaborate with other leading scientists in the field.

Collaborations

Throughout his career, Antonio has worked alongside talented colleagues such as Alejandro Jose Daniels and Dennis Heyer. These collaborations have fostered a dynamic research environment that encourages innovation and discovery.

Conclusion

Antonio Landavazo's contributions to neuropeptide research and his patent on neuropeptide Y antagonists highlight his role as an influential inventor in the scientific community. His ongoing work at Glaxo Wellcome Inc. promises to yield further advancements in this important field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…